Intractable Epilepsy and Progressive Cognitive Decline in a Young Man
暂无分享,去创建一个
[1] P. Striano,et al. Progressive myoclonic epilepsies , 2014, Neurology.
[2] H. Goebel,et al. Human pathology in NCL. , 2013, Biochimica et biophysica acta.
[3] S. Grossi,et al. Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment in two patients , 2009, Journal of Neurology.
[4] R. Vanninen,et al. Clinical picture of EPM1‐Unverricht‐Lundborg disease , 2008, Epilepsia.
[5] A. Delgado-Escueta. Advances in Lafora progressive myoclonus epilepsy , 2007, Current neurology and neuroscience reports.
[6] N. Delanty,et al. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects , 2005, The Lancet Neurology.
[7] R. Michelucci,et al. Lafora disease due to EPM2B mutations , 2005, Neurology.
[8] S. Scherer,et al. Progressive myoclonus epilepsy with polyglucosans (Lafora disease) , 2004, Neurology.
[9] S. Scherer,et al. Skin biopsy in Lafora disease , 2003, Neurology.
[10] R. Michelucci,et al. A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). , 1999, Human molecular genetics.
[11] E. Shoubridge,et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. , 1989, Brain : a journal of neurology.
[12] Gonzalo R. Lafora,et al. Beitrag zur Histopathologie der myoklonischen Epilepsie , 1911 .
[13] O. Onodera,et al. Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.